- Medscape: Medscape Access
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site. Medscape uses cookies to customize the site based on the ...
- Disparate stroke rates on warfarin among contemporaneous cohorts ...
Patients in SPORTIF V were at half the risk as those in SPORTIF III. We found that lower international normalized ratio variability, a higher proportion of prevalent ...
- Ximelagatran or Warfarin for Stroke Prevention in Patients With ...
The results have been published recently. 18 In contrast, in SPORTIF V treatment with ximelagatran or warfarin was randomly allocated double-blind to ...
- Ximelagatran vs Warfarin for Stroke Prevention in Patients With ...
SPORTIF Executive Steering Committee for the SPORTIF V Investigators * Authors/SPORTIF Executive Steering Committee: Stanford Stroke Center, Palo Alto, Calif (Gregory ...
- Karolinska Stroke Update Meeting | Stockholm - Sweden
Thrombin inhibitors: What can we learn from SPORTIF III and SPORTIF V: Ximelagatran versus Warfarin? Gudrun Boysen . Dept. of Neurology, Bispebjerg ...
- NDA-Modified-Template
Figure 7: Patient disposition in SPORTIF V (Figure taken from Figure 4 of SPORTIF V CSR) As seen in Figure 7. above, 841 patients were enrolled but not ...
- Stroke Prevention Using the Oral Direct Thrombin Inhibitor ...
Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Nonvalvular Atrial Fibrillation . SPORTIF V Trial
- theheart.org: trusted cardiology news and opinions
The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.
- Warfarin Better than Dabigatran and Vice Versa in Some Patients ...
Interestingly, these differences in event rates are almost identical to those reported in a post-hoc analysis of the SPORTIF III and SPORTIF V trials (data not shown, see ...
- ROCKET-AF with rivaroxaban enrolls high-risk patients
... 90% have a CHADS2 score of 3 or higher, Hacker said, compared with fewer than 50% of those enrolled in four comparable studies, RE-LY, ACTIVE W, AMADEUS, and SPORTIF V ...